Issue #5 2015 – Digital edition

22 October 2015  •  Author(s): European Pharmaceutical Review

In the digital version of Issue #5 2015:

  • European Pharmaceutical Review Issue #5 2015FOREWORD: The importance of good distribution practice
    David Elder, GlaxoSmithKline and JPAG
  • COUNTERFEIT DRUGS: Counterfeit medicines and the need for a global approach
    David Shore, Pfizer
  • REGULATORY INSIGHT: New third-party audit scheme for excipient suppliers
    Iain Moore, President, EXCiPACT asbl
    Featuring articles from Sulaf Assi, Bournemouth University, Sulayman A. Oladepo, Hui Wang, David Barona and Reinhard Vehring, University of Alberta
  • PAT SERIES: Continuous manufacturing in pharma – an unstoppable trend?
    Bernhard Gutmann and Christian Oliver Kappe, University of Graz
  • POLYMORPHS: Promiscuous multicomponent drug crystals
    Masataka Ito, Kiyohiko Sugano and Katsuhide Terada, Faculty of Pharmaceutical Sciences, Toho University
    Featuring articles from David Roesti and Erik Wilkens, Novartis, Mostafa Eissa, Hikma Pharmaceuticals, and Hideharu Shintani, Chuo University
  • PARTICLE SIZING: Meeting biopharmaceutical analytical requirements for subvisible particle sizing and counting
    John Carpenter, University of Colorado, Amber Haynes Fradkin, KBI Biopharma, and Christina Vessely, Biologics Consulting Group Inc.
  • FREEZE DRYING: Dynamic vapour sorption of freeze-dried pharmaceuticals
    Claudia Kunz & Henning Gieseler, University of Erlangen

The rest of this content is restricted to logged-in subscribers. Login or register (it's free!) to view the full content.

Comments are closed.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...